Back to search
Irritable Bowel Syndrome-bile Acid Diarrhea
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Irritable Bowel Syndrome-bile Acid Diarrhea trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Irritable Bowel Syndrome-bile Acid Diarrhea trials you may qualify forThis is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge…
The purpose of this study is the effect of a study bar, which contains 15 grams of insoluble dietary fiber total sourced from Hemp hulls, on intestinal permeabi…
This single-center, randomized, double-blind, placebo-controlled study is designed to compare effects of aldafermin, (NGM282), 1 mg, and placebo given daily by…
This study will evaluate the possibility of a differential effect of eluxadoline on altered bowel function in Irritable Bowel Syndrome with Diarrhea (IBS-D) par…
To compare with a randomized trial (n=15 per treatment group), effects of colesevelam and placebo treatment, on colonic transit, bowel functions, permeability a…
The investigators' hypothesis is that therapy with Colesevelam, reduces fecal bile acid excretion in patients with Irritable Bowel Syndrome (IBS)-diarrhea with…
Our hypothesis is that the medication approved for treatment of high blood cholesterol levels, Colesevelam HCl (WELCHOL), decreases colonic transit and permeabi…